SCIENTURE HOLDINGS, INC. Cash
SCIENTURE HOLDINGS, INC. (SCNX) had Cash of $3.54 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-05-15
- 2026-03-31: Cash $3.54M.
- 2025-12-31: Cash $6.70M.
- 2025-09-30: Cash $355.69K.
- 2025-06-30: Cash $15.39K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-03-31 | $3.54M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $6.70M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $355.69K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $15.39K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.05M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $308.10K 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $579.10K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $7.72M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $3.50M 10-Q · filed 2024-06-26 | |
| 2023-12-31 | $314.00 10-K · filed 2025-03-26 | $151.91K 10-K · filed 2024-04-22 |
| 2023-09-30 | $34.03K 10-Q · filed 2024-01-16 | |
| 2023-06-30 | $746.00K 10-Q · filed 2023-08-18 | |
| 2019-03-31 | $533.93K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $869.56K 10-Q · filed 2019-05-13 | |
| 2018-03-31 | $189.84K 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $183.91K 10-Q · filed 2019-05-13 | |
| 2017-03-31 | $170.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $14.68K 10-K · filed 2019-03-22 | |
| 2016-09-30 | $94.55K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $319.59K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $508.28K 10-Q · filed 2016-04-20 | |
| 2015-12-31 | $78.71K 10-K · filed 2017-03-30 | $860.13K 10-K · filed 2016-03-28 |
| 2015-09-30 | $324.62K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $414.17K 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $335.30K 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $705.60K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $270.85K 10-Q · filed 2014-10-30 | |
| 2013-12-31 | $84.32K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |